藿香 및 廣藿香의 위장관 효능에 대한 실험연구 고찰
Review of Experimental Researches on Gastrointestinal Activity of Agastache rugosa (Fisch. & C. A. Mey.) Kuntze and Pogostemon cablin (Blanco) Benth.
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The pharmacological rationale of Agastache rugosa (AR) or Pogostemon cablin (PC), which have been used in traditional Korean medicine to treat dampness pattern or syndrome in gastrointestinal tract, was investigated on the gastrointestinal disorders. In-vivo model studies that examined the effect on the gastrointestinal disorders of AR or PC were collected. They were classified into disease-induced in-vivo models or non-disease in vivo models. The target disease, animal species, induction method, administration, and outcomes (changes in morphological and histological parameter, or blood and fluid) of each study were analyzed. The therapeutic mechanism of AR or PC extract was evaluated by the induced diseases and the changes in outcomes. There were contradictory reports on gastrointestinal motility of AR or PC in disease non-disease in-vivo model. AR or PC inhibited gastrointestinal motility in disease model of increased gastrointestinal motility, while promoted motility in disease model of decreased gastrointestinal motility. AR or PC also inhibited inflammatory changes in gastrointestinal inflammation model. These results suggest that the bidirectional regulation of gastrointestinal motility and the improvement of gastrointestinal inflammatory disorders might underpin traditional therapeutic effect of AR or PC, that is effect to resolve dampness of gastrointestinal tract.
Abstract
The pharmacological rationale of Agastache rugosa (AR) or Pogostemon cablin (PC), which have been used in traditional Korean medicine to treat dampness pattern or syndrome in gastrointestinal tract, was investigated on the gastrointestinal disorders. In-vivo model studies that examined the effect on the gastrointestinal disorders of AR or PC were collected. They were classified into disease-induced in-vivo models or non-disease in vivo models. The target disease, animal species, induction method, administration, and outcomes (changes in morphological and histological parameter, or blood and fluid) of each study were analyzed. The therapeutic mechanism of AR or PC extract was evaluated by the induced diseases and the changes in outcomes. There were contradictory reports on gastrointestinal motility of AR or PC in disease non-disease in-vivo model. AR or PC inhibited gastrointestinal motility in disease model of increased gastrointestinal motility, while promoted motility in disease model of decreased gastrointestinal motility. AR or PC also inhibited inflammatory changes in gastrointestinal inflammation model. These results suggest that the bidirectional regulation of gastrointestinal motility and the improvement of gastrointestinal inflammatory disorders might underpin traditional therapeutic effect of AR or PC, that is effect to resolve dampness of gastrointestinal tract.
참고문헌 (29)
- Ministry of Food and Drug Safety., "Korean Pharmacopeia 11th ed", ~ (2014)
- Ju YS., "Ungok Herboloby", pp.685~689 (2013), Woosuk Press
- Chen X, "Effects of Herba Pogostemonis on gastrointestinal tract. the intestinal function", Chin Mat Med, 21(9), pp.462~466 (1998)
- Mei Q, "Construction of pharmacodynamic fingerprint and analysis of spectrum effect relationship on anti-gastrointestinal propulsive of Herba Pogostemonis", Chin Med Herald, 10(35), pp.17~20 (2013)
- Zhu J, "Experimental study for effects of some Chinese herbals on gastrointestinal motility", China J Basic Med Tradit Chin Med, 6(1), pp.21~23 (2000)
- Zhu JZ, "The effects of Agastache rugosa decoction on distribution of intestinal nitric oxide synthase in rats", J Fujian Med, 24(3), pp.99~100 (2002)
- Chen JL, "The effect of Agastache rugosa and its different chemical compositions on the glucose metabolism of mice", J Chin Med Mat, 38(6), pp.1266~1269 (2015)
- 홍지영, "한약재 추출물 및 유래 화합물들의 위장관 운동 촉진 효능 연구", 생약학회지, 45(3), pp.187~193 (2014), 한국생약학회
- Yang Y, "Anti-emetic principles of Pogostemon cablin(Blanco)Benth", Phytomedicine, 6(2), pp.89~93 (1999)
- Lu Y, "The effect of Agastache rugosa on the gastrointestinal hormone of rats with irritable bowel syndrome", J Tradit Chin Med, 51(S1), pp.237~239 (2015)
- Xu M, "Ｒelativity research on the influence of gastrointestinal motility and aerobic metabolism of disorder of gastrointestinal motility mice by Sichuan Agastache rugosus", Pharmacol Clin Chin Mat Med, 30(6), pp.81~84 (2014)
- 이정수, "藿香 抽出物이 腸運動에 미치는 影響", 대한한방내과학회지, 26(4), pp.761~766 (2005), 대한한방내과학회
- Xie YC, "Protective effect of Pogostemon cablin on membrane fluidity of intestinal epithelial cell lin ischemia", reperfusion rats after ischemia, Chin J Integr Trad West Med, pp.2009, 29(7)[DOI]
- Xie YC, "Protective effect of Pogostemon cablin voltile oil on intestinal barrier function", Chin Tradit Herbal Drugs, 40(6), pp.942~944 (2009)
- 박수영, "Protective effects of Pogostemon cablin Bentham water extract on inflammatory cytokine expression in TNBS-induced colitis in rats", Archives of Pharmacal Research, 37(2), pp.253~262 (2014), 대한약학회
- Liu Y, "Effects of volatile oil of Pogostemon cablin on the expression of tight junction protein ZO-1 and occludin in colonic mucosal epithelial cells of rats with post-infectious irritable bowel syndrome", China Pharmacy, 27(16), pp.2190~2193 (2016)
- Zheng YF, "Gastroprotective effect and mechanism of patchouli alcohol against ethanol, indomethacin and stress-induced ulcer in rats", Chem Biol Interact, 222, pp.27~36 (2014)
- Chen XY, "The gastroprotective effect of pogostone from Pogostemonis Herba against indomethacin-induced gastric ulcer in rats", Exp Biol Med, 241, pp.193~204 (2016)
- Koch TR, "Somatostatin in the idiopathic inflammatory bowel diseases", Dis Colon Rectum, 31(3), pp.198~203 (1988)
- Ormsbee HS, "Somatostatin inhibits motilin-induced interdigestive contractile activity in the dog", Dig Dis, 23(9), pp.781~788 (1978)
- Lüdtke FE, "Direct effects of motilin on isolated smooth muscle from various regions of the human stomach", Pflügers Archiv, 414, pp.558~563 (1989)
- Luiking YC, "Differential effects of motilin on interdigestive motility of the human gastric antrum, pylorus, small intestine and gallbladder", Neurogast Mot, 15, pp.103~111 (2003)
- Waldum HL, "Gastrin-histamine sequence in the regulation of gastric acid secretion", Gut, 32, pp.698~701 (1991)
- Calignano A, "Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo", Eur J Pharmacol, 229, pp.273~276 (1992)
- Luk GD, "Diamine oxidase(Histaminase)", J Clin Invest, 66, pp.66~70 (1980)
- Chanarin I, "Absorption of folic acid and D-xylose as tests of small-intestinal function", Br Med J, 1(5283), pp.985~989 (1962)
- Piche T, "Impaired intestinal barrier integrity in the colon of irritable bowel syndrome patients : involvement of soluble mediators", Gut, 58(2), pp.196~201 (2009)
- Coëffier M, "Increased proteasome-mediated degradation of occludin in irritable bowel syndrome", Am J Gastroenterol, 105, pp.1181~1188 (2010)
- Bertiaux-Vandaële N, "The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype", Am J Gastroenterol, 106, pp.2165~2173 (2011)